Developing biomarker-based tools for cancer screening, diagnosis, and treatment :: the state of the science, evaluation, implementation, and economics : workshop summary /
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Körperschaften: | , |
| Weitere Verfasser: | |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C. :
National Academies Press,
©2006.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 1 online resource (x, 102 pages) : illustrations |
| Bibliographie: | Includes bibliographical references (page 92). |
| ISBN: | 9780309658140 0309658144 1280704926 9781280704925 |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocm80168779 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 070126s2006 dcua obt 100 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d YDXCP |d OCLCQ |d COD |d IDEBK |d OCLCQ |d NTE |d TFW |d OCLCQ |d OCLCA |d OCLCF |d OCLCQ |d COO |d NLGGC |d OCLCA |d OCLCQ |d OCL |d EBLCP |d OCLCQ |d TOA |d AGLDB |d ZCU |d OCLCQ |d MERUC |d OCLCQ |d MERER |d OCLCO |d BUF |d OCLCO |d GILDS |d VNS |d VTS |d ICG |d OCLCQ |d OCLCO |d VT2 |d OCLCQ |d LVT |d STF |d WYU |d OCLCO |d DKC |d OCLCQ |d M8D |d UKAHL |d OCLCQ |d OCLCA |d OCLCQ |d OCLCO |d SFB |d OCLCQ |d OCLCO |d OCLCA |d OCLCL | ||
| 016 | 7 | |a 101284309 |2 DNLM | |
| 019 | |a 80788951 |a 144225573 |a 748538904 |a 814470306 |a 923277128 |a 1055343085 |a 1061008044 |a 1061031298 |a 1062925274 |a 1156333220 |a 1228558181 |a 1249244865 |a 1264799208 | ||
| 020 | |a 9780309658140 |q (electronic bk.) | ||
| 020 | |a 0309658144 |q (electronic bk.) | ||
| 020 | |a 1280704926 | ||
| 020 | |a 9781280704925 | ||
| 020 | |z 0309101344 | ||
| 020 | |z 9780309101349 | ||
| 035 | |a (OCoLC)80168779 |z (OCoLC)80788951 |z (OCoLC)144225573 |z (OCoLC)748538904 |z (OCoLC)814470306 |z (OCoLC)923277128 |z (OCoLC)1055343085 |z (OCoLC)1061008044 |z (OCoLC)1061031298 |z (OCoLC)1062925274 |z (OCoLC)1156333220 |z (OCoLC)1228558181 |z (OCoLC)1249244865 |z (OCoLC)1264799208 | ||
| 050 | 4 | |a RC270.3.T84 |b P38 2006eb | |
| 060 | 4 | |a QZ 266 |b P299d 2006 | |
| 072 | 7 | |a MED |x 062000 |2 bisacsh | |
| 072 | 7 | |a HEA |x 039030 |2 bisacsh | |
| 072 | 7 | |a M |2 bicssc | |
| 082 | 7 | |a 616.99/4075 |2 22 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Patlak, Margie. |0 http://id.loc.gov/authorities/names/n2002014880 | |
| 245 | 1 | 0 | |a Developing biomarker-based tools for cancer screening, diagnosis, and treatment : |b the state of the science, evaluation, implementation, and economics : workshop summary / |c Margie Patlak and Sharyl Nass, rapporteurs ; National Cancer Policy Forum. |
| 260 | |a Washington, D.C. : |b National Academies Press, |c ©2006. | ||
| 300 | |a 1 online resource (x, 102 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references (page 92). | ||
| 536 | |a Study supported by contracts between the National Academy of Sciences and the Dept. of Health and Human Services |b HHSH25056133 |b HHSN261200611002C |b 200-2005-13434 |b HHSM-500-2005-00179P |b HHSP23320042509XI |b 223-01-2460 | ||
| 505 | 0 | |a Cover -- Reviewers -- Contents -- Introduction -- Overview of Technologies Used to Discover Cancer Biomarkers -- Genomics, Proteomics, and Metabolomics -- Molecular Imaging -- Meeting the Technical Challenges of Biomarker Validation and Qualification -- Coordinating the Development of Biomarkers and Targeted Therapies -- Therapeutics Industry Perspective -- Diagnostics Industry Perspective -- NCI Perspective -- Clinical Investigator Perspective -- Biomarker Development and Regulatory Oversight -- FDA Critical Path Initiative -- Oversight of Diagnostic Tests -- Designing Clinical Studies of Biomarkers -- Assessment and Adoption of Biomarker-Based Technologies -- Federal Programs for Technology Assessment -- Insurance Coverage Decisions and Practice Guidelines -- CMS Coverage of Biomarkers -- Economic Impact of Biomarkers -- Cost-Effectiveness Analysis -- The Value of Information and Research -- Technology Assessment in the Private Sector -- Clinical Development Strategies for Biomarker Utilization Discussion -- Strategies for Implementing Standardized Biorepositories Discussion -- Strategies for Determining Analytic Validity and Clinical Utility of Biomarkers Discussion -- Strategies to Develop Biomarkers for Early Detection Discussion -- Mechanisms for Developing an Evidence Base Discussion -- Evaluation of Evidence in Decision Making Discussion -- Incorporating Biomarker Evidence Into Clinical Practice Discussion -- Acronyms -- Glossary -- References -- Appendixes -- Appendix A Workshop Agenda -- Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants -- Last Page. | |
| 588 | 0 | |a Print version record. | |
| 650 | 0 | |a Tumor markers |v Congresses. | |
| 650 | 1 | 2 | |a Neoplasms |x prevention & control |0 https://id.nlm.nih.gov/mesh/D009369Q000517 |
| 650 | 2 | 2 | |a Mass Screening |x methods |0 https://id.nlm.nih.gov/mesh/D008403Q000379 |
| 650 | 2 | 2 | |a Biomarkers, Tumor |x analysis. |
| 650 | 6 | |a Marqueurs tumoraux |v Congrès. | |
| 650 | 7 | |a MEDICAL |x Oncology. |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x Cancer. |2 bisacsh | |
| 650 | 7 | |a Tumor markers |2 fast | |
| 655 | 2 | |a Congress |0 https://id.nlm.nih.gov/mesh/D016423 | |
| 655 | 7 | |a proceedings (reports) |2 aat | |
| 655 | 7 | |a Conference papers and proceedings |2 fast | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft |0 http://id.loc.gov/authorities/genreForms/gf2014026068 | |
| 655 | 7 | |a Actes de congrès. |2 rvmgf | |
| 700 | 1 | |a Nass, Sharyl J. |0 http://id.loc.gov/authorities/names/n2001127655 | |
| 710 | 2 | |a National Cancer Policy Forum (U.S.) |0 http://id.loc.gov/authorities/names/n2006183479 | |
| 710 | 1 | |a United States. |b Department of Health and Human Services. |0 http://id.loc.gov/authorities/names/n80102594 | |
| 758 | |i has work: |a Developing biomarker-based tools for cancer screening, diagnosis, and treatment (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGtKHBvVDCRTRpkbWXMJcK |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Patlak, Margie. |t Developing biomarker-based tools for cancer screening, diagnosis, and treatment. |d Washington, D.C. : National Academies Press, ©2006 |z 0309101344 |z 9780309101 |w (DLC) 2006025684 |w (OCoLC)70874173 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=178871 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36616883 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36567697 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3378153 | ||
| 938 | |a EBSCOhost |b EBSC |n 178871 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 70492 | ||
| 938 | |a YBP Library Services |b YANK |n 2514804 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocm80168779 |
|---|---|
| _version_ | 1816881644674482177 |
| adam_text | |
| any_adam_object | |
| author | Patlak, Margie |
| author2 | Nass, Sharyl J. |
| author2_role | |
| author2_variant | s j n sj sjn |
| author_GND | http://id.loc.gov/authorities/names/n2002014880 http://id.loc.gov/authorities/names/n2001127655 |
| author_corporate | National Cancer Policy Forum (U.S.) United States. Department of Health and Human Services |
| author_corporate_role | |
| author_facet | Patlak, Margie Nass, Sharyl J. National Cancer Policy Forum (U.S.) United States. Department of Health and Human Services |
| author_role | |
| author_sort | Patlak, Margie |
| author_variant | m p mp |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RC270 |
| callnumber-raw | RC270.3.T84 P38 2006eb |
| callnumber-search | RC270.3.T84 P38 2006eb |
| callnumber-sort | RC 3270.3 T84 P38 42006EB |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-4-EBA |
| contents | Cover -- Reviewers -- Contents -- Introduction -- Overview of Technologies Used to Discover Cancer Biomarkers -- Genomics, Proteomics, and Metabolomics -- Molecular Imaging -- Meeting the Technical Challenges of Biomarker Validation and Qualification -- Coordinating the Development of Biomarkers and Targeted Therapies -- Therapeutics Industry Perspective -- Diagnostics Industry Perspective -- NCI Perspective -- Clinical Investigator Perspective -- Biomarker Development and Regulatory Oversight -- FDA Critical Path Initiative -- Oversight of Diagnostic Tests -- Designing Clinical Studies of Biomarkers -- Assessment and Adoption of Biomarker-Based Technologies -- Federal Programs for Technology Assessment -- Insurance Coverage Decisions and Practice Guidelines -- CMS Coverage of Biomarkers -- Economic Impact of Biomarkers -- Cost-Effectiveness Analysis -- The Value of Information and Research -- Technology Assessment in the Private Sector -- Clinical Development Strategies for Biomarker Utilization Discussion -- Strategies for Implementing Standardized Biorepositories Discussion -- Strategies for Determining Analytic Validity and Clinical Utility of Biomarkers Discussion -- Strategies to Develop Biomarkers for Early Detection Discussion -- Mechanisms for Developing an Evidence Base Discussion -- Evaluation of Evidence in Decision Making Discussion -- Incorporating Biomarker Evidence Into Clinical Practice Discussion -- Acronyms -- Glossary -- References -- Appendixes -- Appendix A Workshop Agenda -- Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants -- Last Page. |
| ctrlnum | (OCoLC)80168779 |
| dewey-full | 616.99/4075 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4075 |
| dewey-search | 616.99/4075 |
| dewey-sort | 3616.99 44075 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>06077cam a2200745 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocm80168779 </controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">070126s2006 dcua obt 100 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">COD</subfield><subfield code="d">IDEBK</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NTE</subfield><subfield code="d">TFW</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">COO</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCL</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">TOA</subfield><subfield code="d">AGLDB</subfield><subfield code="d">ZCU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MERER</subfield><subfield code="d">OCLCO</subfield><subfield code="d">BUF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">GILDS</subfield><subfield code="d">VNS</subfield><subfield code="d">VTS</subfield><subfield code="d">ICG</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">VT2</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">LVT</subfield><subfield code="d">STF</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">M8D</subfield><subfield code="d">UKAHL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">SFB</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101284309</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">80788951</subfield><subfield code="a">144225573</subfield><subfield code="a">748538904</subfield><subfield code="a">814470306</subfield><subfield code="a">923277128</subfield><subfield code="a">1055343085</subfield><subfield code="a">1061008044</subfield><subfield code="a">1061031298</subfield><subfield code="a">1062925274</subfield><subfield code="a">1156333220</subfield><subfield code="a">1228558181</subfield><subfield code="a">1249244865</subfield><subfield code="a">1264799208</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309658140</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309658144</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1280704926</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781280704925</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309101344</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309101349</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)80168779</subfield><subfield code="z">(OCoLC)80788951</subfield><subfield code="z">(OCoLC)144225573</subfield><subfield code="z">(OCoLC)748538904</subfield><subfield code="z">(OCoLC)814470306</subfield><subfield code="z">(OCoLC)923277128</subfield><subfield code="z">(OCoLC)1055343085</subfield><subfield code="z">(OCoLC)1061008044</subfield><subfield code="z">(OCoLC)1061031298</subfield><subfield code="z">(OCoLC)1062925274</subfield><subfield code="z">(OCoLC)1156333220</subfield><subfield code="z">(OCoLC)1228558181</subfield><subfield code="z">(OCoLC)1249244865</subfield><subfield code="z">(OCoLC)1264799208</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC270.3.T84</subfield><subfield code="b">P38 2006eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">QZ 266</subfield><subfield code="b">P299d 2006</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">062000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HEA</subfield><subfield code="x">039030</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">M</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.99/4075</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Patlak, Margie.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2002014880</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Developing biomarker-based tools for cancer screening, diagnosis, and treatment :</subfield><subfield code="b">the state of the science, evaluation, implementation, and economics : workshop summary /</subfield><subfield code="c">Margie Patlak and Sharyl Nass, rapporteurs ; National Cancer Policy Forum.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington, D.C. :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">©2006.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (x, 102 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (page 92).</subfield></datafield><datafield tag="536" ind1=" " ind2=" "><subfield code="a">Study supported by contracts between the National Academy of Sciences and the Dept. of Health and Human Services</subfield><subfield code="b">HHSH25056133</subfield><subfield code="b">HHSN261200611002C</subfield><subfield code="b">200-2005-13434</subfield><subfield code="b">HHSM-500-2005-00179P</subfield><subfield code="b">HHSP23320042509XI</subfield><subfield code="b">223-01-2460</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Cover -- Reviewers -- Contents -- Introduction -- Overview of Technologies Used to Discover Cancer Biomarkers -- Genomics, Proteomics, and Metabolomics -- Molecular Imaging -- Meeting the Technical Challenges of Biomarker Validation and Qualification -- Coordinating the Development of Biomarkers and Targeted Therapies -- Therapeutics Industry Perspective -- Diagnostics Industry Perspective -- NCI Perspective -- Clinical Investigator Perspective -- Biomarker Development and Regulatory Oversight -- FDA Critical Path Initiative -- Oversight of Diagnostic Tests -- Designing Clinical Studies of Biomarkers -- Assessment and Adoption of Biomarker-Based Technologies -- Federal Programs for Technology Assessment -- Insurance Coverage Decisions and Practice Guidelines -- CMS Coverage of Biomarkers -- Economic Impact of Biomarkers -- Cost-Effectiveness Analysis -- The Value of Information and Research -- Technology Assessment in the Private Sector -- Clinical Development Strategies for Biomarker Utilization Discussion -- Strategies for Implementing Standardized Biorepositories Discussion -- Strategies for Determining Analytic Validity and Clinical Utility of Biomarkers Discussion -- Strategies to Develop Biomarkers for Early Detection Discussion -- Mechanisms for Developing an Evidence Base Discussion -- Evaluation of Evidence in Decision Making Discussion -- Incorporating Biomarker Evidence Into Clinical Practice Discussion -- Acronyms -- Glossary -- References -- Appendixes -- Appendix A Workshop Agenda -- Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants -- Last Page.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Tumor markers</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Neoplasms</subfield><subfield code="x">prevention & control</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D009369Q000517</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Mass Screening</subfield><subfield code="x">methods</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D008403Q000379</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Biomarkers, Tumor</subfield><subfield code="x">analysis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Marqueurs tumoraux</subfield><subfield code="v">Congrès.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Oncology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS</subfield><subfield code="x">Diseases</subfield><subfield code="x">Cancer.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumor markers</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Congress</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D016423</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">proceedings (reports)</subfield><subfield code="2">aat</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Conference papers and proceedings</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Conference papers and proceedings.</subfield><subfield code="2">lcgft</subfield><subfield code="0">http://id.loc.gov/authorities/genreForms/gf2014026068</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Actes de congrès.</subfield><subfield code="2">rvmgf</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nass, Sharyl J.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2001127655</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Cancer Policy Forum (U.S.)</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2006183479</subfield></datafield><datafield tag="710" ind1="1" ind2=" "><subfield code="a">United States.</subfield><subfield code="b">Department of Health and Human Services.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n80102594</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Developing biomarker-based tools for cancer screening, diagnosis, and treatment (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGtKHBvVDCRTRpkbWXMJcK</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Patlak, Margie.</subfield><subfield code="t">Developing biomarker-based tools for cancer screening, diagnosis, and treatment.</subfield><subfield code="d">Washington, D.C. : National Academies Press, ©2006</subfield><subfield code="z">0309101344</subfield><subfield code="z">9780309101</subfield><subfield code="w">(DLC) 2006025684</subfield><subfield code="w">(OCoLC)70874173</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=178871</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36616883</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36567697</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3378153</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">178871</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">70492</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">2514804</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| genre | Congress https://id.nlm.nih.gov/mesh/D016423 proceedings (reports) aat Conference papers and proceedings fast Conference papers and proceedings. lcgft http://id.loc.gov/authorities/genreForms/gf2014026068 Actes de congrès. rvmgf |
| genre_facet | Congress proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès. |
| id | ZDB-4-EBA-ocm80168779 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:16:00Z |
| institution | BVB |
| institution_GND | http://id.loc.gov/authorities/names/n2006183479 http://id.loc.gov/authorities/names/n80102594 |
| isbn | 9780309658140 0309658144 1280704926 9781280704925 |
| language | English |
| oclc_num | 80168779 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (x, 102 pages) : illustrations |
| psigel | ZDB-4-EBA |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | National Academies Press, |
| record_format | marc |
| spelling | Patlak, Margie. http://id.loc.gov/authorities/names/n2002014880 Developing biomarker-based tools for cancer screening, diagnosis, and treatment : the state of the science, evaluation, implementation, and economics : workshop summary / Margie Patlak and Sharyl Nass, rapporteurs ; National Cancer Policy Forum. Washington, D.C. : National Academies Press, ©2006. 1 online resource (x, 102 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references (page 92). Study supported by contracts between the National Academy of Sciences and the Dept. of Health and Human Services HHSH25056133 HHSN261200611002C 200-2005-13434 HHSM-500-2005-00179P HHSP23320042509XI 223-01-2460 Cover -- Reviewers -- Contents -- Introduction -- Overview of Technologies Used to Discover Cancer Biomarkers -- Genomics, Proteomics, and Metabolomics -- Molecular Imaging -- Meeting the Technical Challenges of Biomarker Validation and Qualification -- Coordinating the Development of Biomarkers and Targeted Therapies -- Therapeutics Industry Perspective -- Diagnostics Industry Perspective -- NCI Perspective -- Clinical Investigator Perspective -- Biomarker Development and Regulatory Oversight -- FDA Critical Path Initiative -- Oversight of Diagnostic Tests -- Designing Clinical Studies of Biomarkers -- Assessment and Adoption of Biomarker-Based Technologies -- Federal Programs for Technology Assessment -- Insurance Coverage Decisions and Practice Guidelines -- CMS Coverage of Biomarkers -- Economic Impact of Biomarkers -- Cost-Effectiveness Analysis -- The Value of Information and Research -- Technology Assessment in the Private Sector -- Clinical Development Strategies for Biomarker Utilization Discussion -- Strategies for Implementing Standardized Biorepositories Discussion -- Strategies for Determining Analytic Validity and Clinical Utility of Biomarkers Discussion -- Strategies to Develop Biomarkers for Early Detection Discussion -- Mechanisms for Developing an Evidence Base Discussion -- Evaluation of Evidence in Decision Making Discussion -- Incorporating Biomarker Evidence Into Clinical Practice Discussion -- Acronyms -- Glossary -- References -- Appendixes -- Appendix A Workshop Agenda -- Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants -- Last Page. Print version record. Tumor markers Congresses. Neoplasms prevention & control https://id.nlm.nih.gov/mesh/D009369Q000517 Mass Screening methods https://id.nlm.nih.gov/mesh/D008403Q000379 Biomarkers, Tumor analysis. Marqueurs tumoraux Congrès. MEDICAL Oncology. bisacsh HEALTH & FITNESS Diseases Cancer. bisacsh Tumor markers fast Congress https://id.nlm.nih.gov/mesh/D016423 proceedings (reports) aat Conference papers and proceedings fast Conference papers and proceedings. lcgft http://id.loc.gov/authorities/genreForms/gf2014026068 Actes de congrès. rvmgf Nass, Sharyl J. http://id.loc.gov/authorities/names/n2001127655 National Cancer Policy Forum (U.S.) http://id.loc.gov/authorities/names/n2006183479 United States. Department of Health and Human Services. http://id.loc.gov/authorities/names/n80102594 has work: Developing biomarker-based tools for cancer screening, diagnosis, and treatment (Text) https://id.oclc.org/worldcat/entity/E39PCGtKHBvVDCRTRpkbWXMJcK https://id.oclc.org/worldcat/ontology/hasWork Print version: Patlak, Margie. Developing biomarker-based tools for cancer screening, diagnosis, and treatment. Washington, D.C. : National Academies Press, ©2006 0309101344 9780309101 (DLC) 2006025684 (OCoLC)70874173 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=178871 Volltext |
| spellingShingle | Patlak, Margie Developing biomarker-based tools for cancer screening, diagnosis, and treatment : the state of the science, evaluation, implementation, and economics : workshop summary / Cover -- Reviewers -- Contents -- Introduction -- Overview of Technologies Used to Discover Cancer Biomarkers -- Genomics, Proteomics, and Metabolomics -- Molecular Imaging -- Meeting the Technical Challenges of Biomarker Validation and Qualification -- Coordinating the Development of Biomarkers and Targeted Therapies -- Therapeutics Industry Perspective -- Diagnostics Industry Perspective -- NCI Perspective -- Clinical Investigator Perspective -- Biomarker Development and Regulatory Oversight -- FDA Critical Path Initiative -- Oversight of Diagnostic Tests -- Designing Clinical Studies of Biomarkers -- Assessment and Adoption of Biomarker-Based Technologies -- Federal Programs for Technology Assessment -- Insurance Coverage Decisions and Practice Guidelines -- CMS Coverage of Biomarkers -- Economic Impact of Biomarkers -- Cost-Effectiveness Analysis -- The Value of Information and Research -- Technology Assessment in the Private Sector -- Clinical Development Strategies for Biomarker Utilization Discussion -- Strategies for Implementing Standardized Biorepositories Discussion -- Strategies for Determining Analytic Validity and Clinical Utility of Biomarkers Discussion -- Strategies to Develop Biomarkers for Early Detection Discussion -- Mechanisms for Developing an Evidence Base Discussion -- Evaluation of Evidence in Decision Making Discussion -- Incorporating Biomarker Evidence Into Clinical Practice Discussion -- Acronyms -- Glossary -- References -- Appendixes -- Appendix A Workshop Agenda -- Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants -- Last Page. Tumor markers Congresses. Neoplasms prevention & control https://id.nlm.nih.gov/mesh/D009369Q000517 Mass Screening methods https://id.nlm.nih.gov/mesh/D008403Q000379 Biomarkers, Tumor analysis. Marqueurs tumoraux Congrès. MEDICAL Oncology. bisacsh HEALTH & FITNESS Diseases Cancer. bisacsh Tumor markers fast |
| subject_GND | https://id.nlm.nih.gov/mesh/D009369Q000517 https://id.nlm.nih.gov/mesh/D008403Q000379 https://id.nlm.nih.gov/mesh/D016423 http://id.loc.gov/authorities/genreForms/gf2014026068 |
| title | Developing biomarker-based tools for cancer screening, diagnosis, and treatment : the state of the science, evaluation, implementation, and economics : workshop summary / |
| title_auth | Developing biomarker-based tools for cancer screening, diagnosis, and treatment : the state of the science, evaluation, implementation, and economics : workshop summary / |
| title_exact_search | Developing biomarker-based tools for cancer screening, diagnosis, and treatment : the state of the science, evaluation, implementation, and economics : workshop summary / |
| title_full | Developing biomarker-based tools for cancer screening, diagnosis, and treatment : the state of the science, evaluation, implementation, and economics : workshop summary / Margie Patlak and Sharyl Nass, rapporteurs ; National Cancer Policy Forum. |
| title_fullStr | Developing biomarker-based tools for cancer screening, diagnosis, and treatment : the state of the science, evaluation, implementation, and economics : workshop summary / Margie Patlak and Sharyl Nass, rapporteurs ; National Cancer Policy Forum. |
| title_full_unstemmed | Developing biomarker-based tools for cancer screening, diagnosis, and treatment : the state of the science, evaluation, implementation, and economics : workshop summary / Margie Patlak and Sharyl Nass, rapporteurs ; National Cancer Policy Forum. |
| title_short | Developing biomarker-based tools for cancer screening, diagnosis, and treatment : |
| title_sort | developing biomarker based tools for cancer screening diagnosis and treatment the state of the science evaluation implementation and economics workshop summary |
| title_sub | the state of the science, evaluation, implementation, and economics : workshop summary / |
| topic | Tumor markers Congresses. Neoplasms prevention & control https://id.nlm.nih.gov/mesh/D009369Q000517 Mass Screening methods https://id.nlm.nih.gov/mesh/D008403Q000379 Biomarkers, Tumor analysis. Marqueurs tumoraux Congrès. MEDICAL Oncology. bisacsh HEALTH & FITNESS Diseases Cancer. bisacsh Tumor markers fast |
| topic_facet | Tumor markers Congresses. Neoplasms prevention & control Mass Screening methods Biomarkers, Tumor analysis. Marqueurs tumoraux Congrès. MEDICAL Oncology. HEALTH & FITNESS Diseases Cancer. Tumor markers Congress proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès. |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=178871 |
| work_keys_str_mv | AT patlakmargie developingbiomarkerbasedtoolsforcancerscreeningdiagnosisandtreatmentthestateofthescienceevaluationimplementationandeconomicsworkshopsummary AT nasssharylj developingbiomarkerbasedtoolsforcancerscreeningdiagnosisandtreatmentthestateofthescienceevaluationimplementationandeconomicsworkshopsummary AT nationalcancerpolicyforumus developingbiomarkerbasedtoolsforcancerscreeningdiagnosisandtreatmentthestateofthescienceevaluationimplementationandeconomicsworkshopsummary AT unitedstatesdepartmentofhealthandhumanservices developingbiomarkerbasedtoolsforcancerscreeningdiagnosisandtreatmentthestateofthescienceevaluationimplementationandeconomicsworkshopsummary |